by Susan Johnson | Apr 27, 2011 | Clinical Trial, JBR Clinical Research
U.S. health regulators have ordered drugmakers to conduct clinical trials involving a total of 53,000 patients to test the safety of a controversial class of inhaled asthma drugs that are already on the market. JeanBrownResearch.com Share This...
